Browsing: Gains

President Donald Trump’s weight has risen sharply over the past year or so, prompting medical experts to warn of health risks. His weight measured in May stood at 108 kilograms, up more than 10 kilograms from the 97.5 kilograms recorded when he was booked at a Georgia jail in August 2023

Shares of Ultragenyx PharmaceuticalRARE are rising in premarket trading today following the FDA’s accelerated approval of DTX-401, an AAV8 gene therapy for glycogen storage disease type Ia (GSDIa)

Latest Class of Stead Scholars Gains Awareness of Public Health | UAMS News Skip to main content

Novo Nordisk (ISIN DK0062498333) stock is trading in the mid-$40s per American depositary receipt after closing at $44.89 on August 17, 2026, leaving the shares down 11.8% year-to-date compared with a level of $50.88 at the start of 2026. Per recent market data, the stock was changing hands at $44.89 at 3:58 p.m. ET on…

In India, the state of Kerala is addressing child malnutrition by using microenterprises to produce and distribute a fortified, wheat-based porridge mix known as Amrutham Nutrimix

In a significant development for weight management and diabetes treatment, Britain’s medicines regulator has authorized Eli Lilly’s new pill, Foundayo. This move makes the UK the first European country to approve the tablet for both conditions

The New Orleans Department of Health and Human Services has released a report detailing progress made under its 2022-2025 Community Health Improvement Plan, citing improvements in overdose prevention, chronic disease outcomes, maternal health and access to care through a broad coalition of public and private partners

Published: 10:46, July 25, 2026 Pet-friendly lifestyle gains momentum in Shenzhen By Zhou Mo in Shenzhen People pose for a photo with their pets at a pet carnival in Shenzhen, China, on July 24, 2026. (YAO XI / FOR CHINA DAILY)

Eton Pharmaceuticals (ETON) drew fresh attention after its stock climbed 13.8% on strong trading volume, with interest centering on its commercial rare disease portfolio and late-stage candidates such as Amglidia and the Zeneo hydrocortisone autoinjector

Novo Nordisk (ISIN DK0060534915) remains one of the most closely watched large-cap healthcare names in Europe, with its shares linked to diabetes and obesity demand, revenue growth, and operating-profit trends. The current market setting is best read through the company’s latest reported numbers and its main investor relations channel, which still frames the stock around…